We identified Sun2 as a gene that is down-expressed in prostate cancer tissues vs.normal tissues, and that low expression of Sun2 was significantly correlated with the high Gleason score, pT, Lymph nodal invasionand clinical pathological stage. This evidence concerns the gene SUN2 and prostate carcinoma.